SCHEMBL1553583

SCHEMBL1553583

CCOC(=O)c1sc(Cl)nc1C(=O)N(C)C

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.50
CYP1A2 P05177 2/20 0.50
GAA P10253 1/20 0.46
MAPT P10636 2/20 0.42
TRPM8 Q7Z2W7 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HPGD P15428 4/20 0.41
MAPK1 P28482 1/20 0.41
CDC7 O00311 2/20 0.40
DBF4 Q9UBU7 2/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1505552 0.86 ALDH1A1 (0.66) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL1553046 0.83 ALDH1A1 (0.54) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL1553063 0.83 ALDH1A1 (0.54) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL2826240 0.82 ALDH1A1 (0.53) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL1554058 0.78 ALDH1A1 (0.49) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL28049117 0.78 ALDH1A1 (0.50) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL187316 0.78 ALDH1A1 (0.59) ALDH1A1GAAMAPTHPGDCDC7
SCHEMBL1553145 0.77 SMN1; SMN2 (0.48) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL2826239 0.77 ALDH1A1 (0.54) ALDH1A1CYP1A2GAAMAPTTRPM8
SCHEMBL1553485 0.76 ALDH1A1 (0.47) ALDH1A1CYP1A2GAAMAPTTRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
EP-2102199-B1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2011-04-27 EP disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
US-7674801-B2 Alkyl urea substituted pyridines ASTRAZENECA AB (SE) 2010-03-09 US disclosed
EP-2102199-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS AstraZeneca AB (SE) 2009-09-23 EP disclosed
WO-2008068470-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2008-06-12 WO disclosed
WO-2008068470-A1 ANTIBACTERIAL POLYCYCLIC UREA COMPOUNDS ASTRAZENECA AB (SE) 2008-06-12 WO disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed
US-20080132546-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2008-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080132546-A1 CHEMICAL COMPOUNDS MRPL21, NISCH, ABCB11 ALDH1A1 488/4885CYP1A2 41/4885GAA 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.